ArticleClinical ophthalmology (Auckland, N.Z.)2025
Relationship Between Intraocular Pressure-Lowering Effects and Alterations in Anterior Segment Scleral Birefringence Following Micropulse Cyclophotocoagulation.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To assess the changes in anterior segment scleral birefringence (ASSB), a marker of collagen-related fibrotic responses, following micropulse cyclophotocoagulation (MP-CPC) using polarization-sensitive optical coherence tomography (PS-OCT). Patients and Methods: Eighteen eyes of sixteen patients with glaucoma who underwent MP-CPC at the University of Tokyo Hospital in Japan from July 2022 to August 2023 were included. The procedure utilized a Cyclo G6 glaucoma laser system (IRIDEX, Mountain View, CA, USA) with laser power set at 2,500 mW and an 80-second duration per hemisphere. Clinical outcomes and ASSB were assessed for 6 months. The principal assessment was the evaluation of post-procedure ASSB. Anterior segment images were captured before MP-CPC, and at 1 week, 1 month, 3 months, and 6 months after MP-CPC, using PS-OCT (ROCTIA; Tomey Corporation, Nagoya, Japan) to assess the ASSB. We also assessed the correlation between intraocular pressure (IOP) reduction and changes in birefringence. Results: The IOP was significantly lower after than before MP-CPC (pretreatment: 24.8 ± 1.8, 1 week: 13.9 ± 1.1, 1 month: 17.4 ± 1.1, 3 months: 20.1 ± 1.7, and 6 months: 19.0 ± 1.6 mmHg). ASSB increased significantly after treatment (pretreatment: 1.00 ± 0.08, 1 week: 1.20 ± 0.11, 1 month: 1.27 ± 0.06, 3 months: 1.42 ± 0.07, and 6 months: 1.26 ± 0.15), suggesting post-laser collagen remodeling in the sclera. Notably, a significant positive correlation was found between the rate of IOP reduction and the degree of birefringence elevation at 3 and 6 months post-procedure. Conclusion: We observed a significant increase in ASSB after MP-CPC, and this increase was positively correlated with IOP reduction. These findings point to the potential mechanism underlying IOP reduction and emphasize the clinical relevance of the birefringence value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.